Peddock Capital Advisors, LLC Gilead Sciences, Inc. Transaction History

Peddock Capital Advisors, LLC

$414 Million
Q3 2024

A detailed history of Peddock Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Peddock Capital Advisors, LLC holds 20,806 shares of GILD stock, worth $1.93 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

20,806

Previous 20,806 -0.0%

Holding current value

$1.93 Million

Previous $1.43 Million 22.14%

% of portfolio

0.42%

Previous 0.37%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	BUY	$73.27 - $83.09 $24,765 - $28,084	338 Added 1.65%	20,806 $1.69 Million
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $10,641 - $12,138	140 Added 0.69%	20,468 $1.58 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $8,504 - $9,688	110 Added 0.54%	20,328 $1.69 Million
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $12,650 - $18,162	203 Added 1.01%	20,218 $1.74 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $32,568 - $37,201	547 Added 2.81%	20,015 $1.24 Million
Q2 2022 Aug 01, 2022	BUY	$57.72 - $65.01 $12,698 - $14,302	220 Added 1.14%	19,468 $1.2 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $601,209 - $753,380	10,380 Added 117.05%	19,248 $1.14 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $89,283 - $96,326	-1,319 Reduced 12.95%	8,868 $619,000
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $23,566 - $26,852	-416 Reduced 3.92%	10,187 $593,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $2,459 - $2,856	-34 Reduced 0.32%	10,603 $816,000
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $4,947 - $6,337	-79 Reduced 0.74%	10,637 $795,000
Q4 2019 Jan 24, 2020	SELL	$61.62 - $67.78 $18,670 - $20,537	-303 Reduced 2.75%	10,716 $696,000
Q2 2019 Aug 06, 2019	SELL	$61.87 - $69.38 $1,237 - $1,387	-20 Reduced 0.18%	11,019 $744,000
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $142,505 - $159,643	-2,279 Reduced 17.11%	11,039 $718,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $130,039 - $169,692	-2,148 Reduced 13.89%	13,318 $833,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $9,551 - $10,575	134 Added 0.87%	15,466 $1.19 Million
Q2 2018 Aug 03, 2018	BUY	$64.88 - $75.68 $64 - $75	1 Added 0.01%	15,332 $1.09 Million
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $21,123 - $25,752	-290 Reduced 1.86%	15,331 $1.16 Million
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $86,660 - $101,727	-1,218 Reduced 7.23%	15,621 $1.12 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.21 Million - $1.44 Million	16,839	16,839 $1.36 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peddock Capital Advisors, LLC with notifications on news.

Account

Peddock Capital Advisors, LLC Gilead Sciences, Inc. Transaction History